SCHEMBL9454471

SCHEMBL9454471

[c]1cccc(-c2ccns2)c1

nearest known ligand 0.37

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
NT5E P21589 1/20 0.34
EP300 Q09472 1/20 0.30
KAT2B Q92831 1/20 0.30
KAT5 Q92993 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6422894 0.74 CYP3A4 (0.47) CYP1A2CYP3A4CYP2D6NT5EEP300
SCHEMBL3182746 0.72
SCHEMBL610112 0.71 ALDH1A1 (0.33)
SCHEMBL5924779 0.69 CNR1 (0.35) CYP3A4CYP2D6
SCHEMBL694294 0.68 CYP3A4 (0.47) CYP1A2CYP3A4CYP2D6
SCHEMBL27176145 0.68 HSD17B1 (0.47) CYP1A2CYP3A4
SCHEMBL3609293 0.68 DYRK1A (0.46) CYP3A4
SCHEMBL2876361 0.68
SCHEMBL297361 0.67 NOTUM (0.54)
SCHEMBL160790 0.67 CYP2A6 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5234946-A Anticholesterol, antilipemic BANYU PHARMACEUTICAL CO., LTD. (JP) 1993-08-10 US disclosed
EP-0318860-B1 SUBSTITUTED ALKYLAMINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1993-06-16 EP disclosed
CN-1037141-A The alkylamine derivative that replaces BANYU PHARMA CO LTD (JP) 1989-11-15 CN disclosed
EP-0318860-A2 Substituted alkylamine derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-06-07 EP disclosed